ADVERTISEMENT
ADVERTISEMENT
Hundred dollar bills with stethoscope on top
Most Medical Papers Didn’t Disclose Industry Payments: Preprint
Authors of papers published in JAMA and NEJM received millions in undisclosed payments in 2017, an analysis finds.
Most Medical Papers Didn’t Disclose Industry Payments: Preprint
Most Medical Papers Didn’t Disclose Industry Payments: Preprint

Authors of papers published in JAMA and NEJM received millions in undisclosed payments in 2017, an analysis finds.

Authors of papers published in JAMA and NEJM received millions in undisclosed payments in 2017, an analysis finds.

industry collaboration

Women looks at computer screen in a lab coat and mask
Quest for Research Freedom Fuels African Biotech Boom
Linda Nordling | Jul 1, 2021 | 6 min read
Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.
The Rise of BCI Enables Advances in Neuroscience
Jef Akst | Oct 1, 2020 | 10+ min read
A nascent but growing consumer market for brain-computer interface technology is driving the development of sleek new tools for decoding brain activity.
Proposed Deep-Sea Mining Zone Harbors Previously Unknown Species
Catherine Offord | Oct 17, 2019 | 5 min read
The discovery of ancient clades of brittle stars at the bottom of the Pacific Ocean adds to concerns that commercial exploitation of the area could destroy numerous taxa before they’ve even been identified.
Industry Partners Extensively Involved in Trials They Fund
Catherine Offord | Oct 5, 2018 | 2 min read
A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.
How to Successfully Collaborate with Industry
Ashley P. Taylor | Mar 1, 2018 | 8 min read
In efforts to translate basic-science results into pharmaceuticals and other technologies, success cannot be taken for granted.
The Rising Research Profile of 23andMe
Catherine Offord | Nov 30, 2017 | 7 min read
An exploration of the genetics of earlobe attachment is just the latest collaborative research project to come out of the personal genetic testing company.
Repurposing Existing Drugs for New Indications
Anna Azvolinsky | Jan 1, 2017 | 10+ min read
An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.
HHS Partners on Ebola Drug
Jef Akst | Jul 22, 2015 | 2 min read
The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.
CAR-T Therapies Get $1 Billion Boost
Bob Grant | Jul 1, 2015 | 2 min read
The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.
Follow the Funding
Bob Grant | May 1, 2015 | 7 min read
In times of budget belt-tightening at the federal level, life-science researchers can keep their work supported through private sources.
 
23andMe Partners with Pfizer
Jef Akst | Jan 13, 2015 | 1 min read
The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.
$230M for Big Disease
Jef Akst | Feb 5, 2014 | 2 min read
The National Institutes of Health is partnering with 10 drug companies to find new treatments for Alzheimer’s disease, diabetes, rheumatoid arthritis, and lupus.
Industry Funds Limit Freedom: Report
Kerry Grens | Nov 27, 2013 | 2 min read
A report by a Canadian organization finds that industry-academia relationships compromise university investigators' liberty.  
Innovation Nation
Megan Scudellari | Jul 1, 2013 | 8 min read
Already a world leader in high-tech entrepreneurship, Israel is now flexing its biotech muscles.
Opinion: Bias Is Unavoidable
Lisa Cosgrove | Aug 7, 2012 | 4 min read
Simply disclosing conflicts of interest is not enough.
Playing Fair with Industry
Sabrina Richards | Jun 13, 2012 | 4 min read
The American Association of University Professors releases recommendations for maintaining academic freedom while collaborating with industry.
ADVERTISEMENT